MYELODYSPLASTIC SYNDROME
Clinical trials for MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for tough blood cancers in older adults
Disease control TerminatedThis study tested how well two chemotherapy drugs, venetoclax and decitabine, work together to control aggressive blood cancers. It was for older adults newly diagnosed with acute myeloid leukemia (AML) or people whose AML or high-risk myelodysplastic syndrome (MDS) had returned …
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Scientists test new combo against tough blood cancers
Disease control TerminatedThis early-stage study tested a combination of two drugs, AZD1775 and belinostat, for patients with advanced blood cancers like acute myeloid leukemia (AML) that have returned or not responded to prior treatments. The main goal was to find the safest and most effective dose of th…
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New drug combo tested for Tough-to-Treat blood cancers
Disease control TerminatedThis study tested a combination of two chemotherapy drugs, venetoclax and azacitidine, for people with high-risk myelodysplastic syndromes (MDS) or related blood cancers. It aimed to find a safe dose and see if the treatment could control the disease, especially for patients whos…
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC